Cynthia Verst

Dr. Cynthia Verst is president, Design and Delivery Innovation, Research & Development Solutions at IQVIA. In this role, Dr. Verst is responsible for driving innovation and transformation throughout the clinical development trial lifecycle. She leads the global, integrated Applied Data Science Center, Therapeutic Science and Strategy Unit, and the Regulatory Affairs and Drug Development Solutions. Having previously served as president of both clinical operations and real-world and late phase research for IQVIA, Dr. Verst brings a holistic and comprehensive view of clinical research, and champions the advanced use of real-world data, analytics and technology to advance new therapies for patients. Recognized by FierceBiotech as a top woman in biotech, and as a PharmaVoice Top 100 leader, she currently sits on the Board of Directors for ACRO and is the past chair of the DIA Board of Directors and is a member of the DIA Fellows.

Prior to joining IQVIA (then Quintiles), she served as senior vice president, Global Late Phase Research for OptumInsight (a division of UnitedHealth Group). Dr. Verst began her career in biopharma at Procter & Gamble Pharmaceuticals as section head in its North American Medical and Technical Affairs group.

Dr. Verst holds a doctorate and bachelor’s degree in Pharmacy from the University of Cincinnati, a master’s degree in Structural and Cellular Biology from the University of Illinois, and bachelor’s degrees in Biology and Chemistry from Northern Kentucky University.